Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 32 pages
Exam (elaborations)

NUR 600 Exam 2 Advanced Pharmacology Galen College of Nursing Question Bank 2026/2027 with Verified Answers & Detailed Rationales

Document preview thumbnail
Preview 4 out of 32 pages

This comprehensive question bank is the definitive resource for Galen College of Nursing students preparing to successfully conquer NUR 600 Exam 2 in Advanced Pharmacology. Featuring a complete collection of exam-aligned questions, this bank thoroughly covers all core topics including pharmacokinetics, pharmacodynamics, drug classifications, adverse effects, drug interactions, and therapeutic management across the lifespan as presented in the NUR 600 curriculum. Each question is carefully constructed to reflect the current exam format and challenge your clinical reasoning abilities. What sets this question bank apart is the detailed answer key providing verified answers with clear, concise rationales for every option. These rationales reinforce essential pharmacological concepts, explain the underlying mechanisms of drug action, and guide you in differentiating between competing therapeutic decisions under timed exam conditions. Consistent use of this resource will build your test-taking confidence, identify knowledge gaps for focused remediation, and ensure you are fully prepared to achieve a competitive score on your first attempt. This is an indispensable tool for any Galen College of Nursing student committed to academic success and excellence in advanced pharmacology. Vertical Keywords NUR 600 Exam 2 Advanced Pharmacology Galen College of Nursing Pharmacokinetics Pharmacodynamics Drug Classifications Adverse Effects Drug Interactions Therapeutic Management Nursing Exam Prep Galen Nursing

Content preview

GALEN COLLEGE OF NURSING · SCHOOL OF NURSING




NUR 600 Exam 2
Practice Question Bank
Advanced Pharmacology — NCLEX-Style Practice Questions with
Rationales



Topic Focus: Dermatology, Ophthalmology, Otolaryngology, Infectious Disease
Pharmacology


Edition 1 · September 2026




Table of Contents

1. Instructions for Use 2

2. Practice Questions with Answers & Rationales — Advanced Pharmacology 2


NUR 600 · Galen College of Nursing Page 1

,NUR 600 EXAM 2 PRACTICE GUIDE INSTRUCTIONS & PRACTICE QUESTIONS




How to Use This Guide
Read each stem, choose your answer, then check the rationale directly below it. The correct
option is marked, and each wrong option is explained so you understand why it's wrong — not
just that it is.



Category: Advanced Pharmacology — Dermatology, Ophthalmology, ENT,
Infectious Disease


1 Topical application of an antihistamine may result in drug toxicity in children. The
parent of a toddler asks the NP about using a topical antihistamine to treat the
child's atopic dermatitis symptoms. The NP should tell the parent to use which
medication instead?

A Hydrocortisone cream
B Triamcinolone acetonide
C Diphenhydramine cream
D Pramoxine lotion


Why B is correct: Topical antihistamines should be avoided in children due to risk of
systemic toxicity. Triamcinolone acetonide is a topical corticosteroid that is appropriate for
treating atopic dermatitis in children.

A — Hydrocortisone may not be potent enough for moderate dermatitis.
C — Diphenhydramine is the antihistamine that should be avoided.
D — Pramoxine is an anesthetic, not appropriate as a primary treatment.

,2 A 5-year-old child has atopic dermatitis that is refractory to treatment with
hydrocortisone acetate 2.5% cream. The primary care NP should prescribe:

A Hydrocortisone valerate 0.2%
B Fluocinolone acetonide 0.01%
C Desonide cream 0.05%
D Clobetasol propionate 0.05%


Why C is correct: Desonide is a low-potency topical corticosteroid appropriate for children
with atopic dermatitis refractory to hydrocortisone.

A — Hydrocortisone valerate is a higher potency steroid.
B — Fluocinolone is a higher potency steroid.
D — Clobetasol is a super-high potency steroid not recommended for children.




3 A patient has been treated for severe contact dermatitis on both arms with
clobetasol propionate cream. At a follow-up visit, the primary care NP notes that the
condition has cleared. The NP should:

A Discontinue the clobetasol immediately
B Prescribe a higher potency steroid
C Prescribe triamcinolone cream for 2 weeks
D Continue clobetasol indefinitely


Why C is correct: After clearing severe contact dermatitis with a high-potency steroid,
stepping down to a mid-potency steroid like triamcinolone for a limited time is appropriate
to prevent relapse.

A — Abrupt discontinuation may cause rebound flare.
B — Higher potency is not needed since the condition has cleared.
D — Long-term use of clobetasol is not recommended.

, 4 A primary care NP prescribes fluocinolone cream for a patient who has contact
dermatitis. At a follow-up visit in 2 weeks, the patient reports decreased pruritus but
continues to have excoriated, erythematous areas. The NP should:

A Increase the fluocinolone concentration
B Add a systemic corticosteroid
C Begin therapy with pimecrolimus (Elidel)
D Refer to a dermatologist


Why C is correct: Pimecrolimus, a topical calcineurin inhibitor, may be used as a non-
steroidal alternative for atopic dermatitis when topical corticosteroids are not fully effective.

A — Increasing concentration may not be sufficient.
B — Systemic corticosteroids are not first-line for this presentation.
D — Referral may be needed but Elidel is appropriate first.




5 A primary care NP is considering using a topical immunosuppressive agent for a
patient who has atopic dermatitis that is refractory to treatment with topical
corticosteroids. The NP should:

A Use tacrolimus in children under 2 years
B Prescribe pimecrolimus for continuous use
C Prescribe pimecrolimus for short-term, intermittent use
D Use pimecrolimus as first-line therapy


Why C is correct: Topical calcineurin inhibitors like pimecrolimus should be used for short-
term, intermittent use in patients refractory to topical corticosteroids.

A — Tacrolimus is not recommended in children under 2 years.
B — Continuous use is not recommended.
D — They are not first-line therapy.

Document information

Uploaded on
September 5, 2026
Number of pages
32
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$12.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
ExamitorMagnus
3.4
(23)
Sold
121
Followers
7
Items
2002
Last sold
2 weeks ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions